CCL2 Antikörper (Middle Region)
Kurzübersicht für CCL2 Antikörper (Middle Region) (ABIN926929)
Target
Alle CCL2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Hund
-
Aufreinigung
- Purified
-
Immunogen
- CCL2 antibody was raised in rabbit using the middle region of CCL2 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CCL2 Blocking Peptide, (ABIN936932), is also available for use as a blocking control in assays to test for specificity of this CCL2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- CCL2 (Chemokine (C-C Motif) Ligand 2 (CCL2))
-
Andere Bezeichnung
- CCL2
-
Hintergrund
- CCL2 is a chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. CCL2 augments monocyte anti-tumor activity. CCL2 has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. CCL2 may be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis. Synonyms: Polyclonal CCL2 antibody, Anti-CCL2 antibody, chemokine, C-C motif ligand 2 antibody, GDCF-2 antibody, GDCF-2 HC11 antibody, HC11 antibody, HSMCR30 antibody, MCAF antibody, MCP-1 antibody, MCP1 antibody, MGC9434 antibody, SCYA2 antibody, SMC-CF antibody.
-
Pathways
- Cellular Response to Molecule of Bacterial Origin, Positive Regulation of Immune Effector Process, ER-Nucleus Signaling, Unfolded Protein Response, Phosphorylierungen bei SARS-CoV-2 Infektion
Target
-